Duration of overweight and metabolic health risk in American men and women

被引:63
作者
Janssen, I
Katzmarzyk, PT
Ross, R [1 ]
机构
[1] Queens Univ, Sch Phys & Hlth Educ, Dept Community Hlth & Epidemiol, Kingston, ON K7L 3N6, Canada
[2] Queens Univ, Dept Med, Div Endocrinol & Metab, Kingston, ON K7L 3N6, Canada
基金
加拿大健康研究院;
关键词
metabolic syndrome; insulin resistance; type; 2; diabetes;
D O I
10.1016/j.annepidem.2004.01.007
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
PURPOSE: To investigate the association between overweight duration and metabolic health risk. METHODS: Subjects consisted of 4874 participants, aged 30 to 64 years, from the Third National Health and Nutrition Examination Survey. Duration of overweight was determined from recalled weights from 10 years prior to the survey. Metabolic health risk was determined from a fasting blood sample and blood pressure measurements. RESULTS: After adjusting for current body mass index, the relative odds for obesity-related comorbidities were not higher in men who had been overweight for < 10 years compared with men with a normal weight. However, the likelihood [odds ratios (95% confidence intervals)] of hypertriglyceridemia [2.39 (1.34-4.27)] and the metabolic syndrome [2.15 (1.01-1.57)] were increased in men who had been overweight for; 10 years compared with normal weight men. In women there was a graded increase (p < 0.001) in the likelihood of numerous metabolic disorders when moving from the normal weight to overweight < 10 year to overweight greater than or equal to 10 year categories. CONCLUSIONS: The duration of overweight has a significant effect on obesity-related comorbidities in men and women. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:585 / 591
页数:7
相关论文
共 36 条
[1]  
[Anonymous], 1998, Obes Res, V6, p51S
[2]  
[Anonymous], NHANES 3 REF MAN REP
[3]  
[Anonymous], 1998, Diabetes Care, V21, pS20, DOI DOI 10.2337/DIACARE.21.1.S20
[4]   Discrimination of health risk by combined body mass index and waist circumference [J].
Ardern, CL ;
Katzmarzyk, PT ;
Janssen, I ;
Ross, R .
OBESITY RESEARCH, 2003, 11 (01) :135-142
[5]   Prevalence of insulin resistance in metabolic disorders - The Bruneck Study [J].
Bonora, E ;
Kiechl, S ;
Willeit, J ;
Oberhollenzer, F ;
Egger, G ;
Targher, G ;
Alberiche, M ;
Bonadonna, RC ;
Muggeo, M .
DIABETES, 1998, 47 (10) :1643-1649
[6]   What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? [J].
Brochu, M ;
Tchernof, A ;
Dionne, IJ ;
Sites, CK ;
Eltabbakh, GH ;
Sims, EAH ;
Poehlman, ET .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (03) :1020-1025
[7]   Body mass index and the prevalence of hypertension and dyslipidemia [J].
Brown, CD ;
Higgins, M ;
Donato, KA ;
Rohde, FC ;
Garrison, R ;
Obarzanek, E ;
Ernst, ND ;
Horan, M .
OBESITY RESEARCH, 2000, 8 (09) :605-619
[8]  
Carlsson S, 1998, AM J EPIDEMIOL, V148, P539, DOI 10.1093/oxfordjournals.aje.a009679
[9]   OBESITY, FAT DISTRIBUTION, AND WEIGHT-GAIN AS RISK-FACTORS FOR CLINICAL DIABETES IN MEN [J].
CHAN, JM ;
RIMM, EB ;
COLDITZ, GA ;
STAMPFER, MJ ;
WILLETT, WC .
DIABETES CARE, 1994, 17 (09) :961-969
[10]   Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].
Chobanian, AV ;
Bakris, GL ;
Black, HR ;
Cushman, WC ;
Green, LA ;
Izzo, JL ;
Jones, DW ;
Materson, BJ ;
Oparil, S ;
Wright, JT ;
Roccella, EJ .
HYPERTENSION, 2003, 42 (06) :1206-1252